Cite
HARVARD Citation
Zhong, M. et al. (2022). Prediction of multiple sclerosis outcomes when switching to ocrelizumab. Multiple sclerosis. pp. 958-969. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhong, M. et al. (2022). Prediction of multiple sclerosis outcomes when switching to ocrelizumab. Multiple sclerosis. pp. 958-969. [Online].